• Thu. Jul 29th, 2021

Dimancherouge

Technology

Anti-Inflammatory Biologics Market 2020: Global Size, Growth Factors, Emerging Technologies, Major Segments, Forecast Research Report 2026

The global “Anti-Inflammatory Biologics Market Size” is expected to reach USD 149.80 billion by 2027, exhibiting a CAGR of 11.0% during the forecast period. The indication of an inflammatory surplus in patients with COVID-19 along with plentiful neutrophils and macrophages will revivify growth prospects for the anti-inflammatory biologics market share during the forecast period. The ongoing trials for anti-tumor necrosis factor (TNF) antibodies in severe cases of autoimmune inflammatory disease such as rheumatoid arthritis, inflammatory bowel disease, or ankylosing spondylitis will aid the speedy expansion of the market during the forecast period, mentioned by Fortune Business Insights, in a report, titled “Anti-Inflammatory Biologics Market Size, Share & Industry Analysis, By Drug Class (Anti-Tumor Necrosis Factor (TNF), Interleukin Antagonists, Janus Kinase (JAK) Inhibitors, Others), By Application (Rheumatoid Arthritis, Psoriasis, and Others), By Route of Administration (Oral and Injection (Subcutaneous and Intravenous)), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027” the market size stood at USD 64.84 billion in 2019.

The report covers:

  • Global Anti-Inflammatory Biologics Market trends, with detailed analysis on consumer trends & manufacturer trends.
  • Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
  • Key areas of investments identifying market opportunities and challenges in forecast timeframe.
  • Competitive analysis of the industry players along with the overview on strategic management.
  • Comprehensive company profiles of the major industry players.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/anti-inflammatory-biologics-market-102733

Leading Players operating in the Anti-Inflammatory Biologics Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

  • AbbVie Inc.
  • Merck & Co., Inc.
  • Bristol-Myers Squibb Company
  • Johnson & Johnson Services, Inc.
  • Pfizer Inc.
  • Novartis AG
  • UCB S.A.
  • Eli Lilly and Company
  • Amgen Inc.
  • Biogen

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/anti-inflammatory-biologics-market-102733

Regional Analysis:

Increasing Cases of Inflammatory Diseases to Boost Growth in North America

The market in North America stood at USD 28.63 billion in 2019. The growth of the region is attributed to rising government support for the introduction of biosimilars in the region. The potential pipeline candidates along with demand for anti-TNF drugs will aid healthy growth of the market in the region. The increasing prevalence of rheumatoid arthritis will spur demand for the market in North America. The approval of novel drugs will favor growth in Europe in the foreseeable future. For instance, in October 2018, Mylan announced the commercial launch of Hulio, a biosimilar of adalimumab. Asia Pacific is predicted to grow rapidly during the forecast period owing to the growing geriatric population. The increasing preference for biologics for inflammatory diseases will boost the market in Asia Pacific. The Middle East and Africa is likely to rise steadily in the forthcoming years owing to the improving healthcare infrastructure and rising disposable income.

Detailed Table of Content:

  1. Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  4. Key Insights
    • Prevalence of Rheumatoid Arthritis & Psoriasis – For Key Countries
    • Pipeline Analysis
    • Patent Snapshot
    • New Product Launches
    • Key Industry Developments – Mergers, Acquisitions and Partnerships
  5. Global Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Drug Class
      • Anti-Tumor Necrosis Factor (TNF)
      • Interleukin Antagonists
      • Janus Kinase (JAK) Inhibitors
      • Others
    • Market Analysis, Insights and Forecast – By Application
      • Rheumatoid Arthritis
      • Psoriasis
      • Others
    • Market Analysis, Insights and Forecast – By Route of Administration
      • Oral
      • Injection
      • Market Analysis, Insights and Forecast – By Distribution Channel
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • Market Analysis, Insights and Forecast – By Region
        • North America
        • Europe
        • Asia Pacific
        • Latin America
        • Middle East & Africa
  1. North America Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Drug Class
      • Anti-Tumor Necrosis Factor (TNF)
      • Interleukin Antagonists
      • Janus Kinase (JAK) Inhibitors
      • Others
    • Market Analysis, Insights and Forecast – By Application
      • Rheumatoid Arthritis
      • Psoriasis
      • Others
    • Market Analysis, Insights and Forecast – By Route of Administration
      • Oral
      • Injection
      • Market Analysis, Insights and Forecast – By Distribution Channel
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • Market Analysis, Insights and Forecast – By Country

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/anti-inflammatory-biologics-market-102733

Report Focus:

  • Extensive product offerings
  • Customer research services
  • Robust research methodology
  • Comprehensive reports
  • Latest technological developments
  • Value chain analysis
  • Potential Anti-Inflammatory Biologics Market opportunities
  • Growth dynamics
  • Quality assurance
  • Post-sales support
  • Regular report updates

Reasons to Purchase this Report:

  • Comprehensive analysis of the Anti-Inflammatory Biologics Market growth drivers, obstacles, opportunities, and other related challenges.
  • Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
  • Identifies market restraints and boosters.
  • Identifies all the possible segments present in the market to aid organizations in strategic business planning.

More Trending Topics from Fortune Business Insights:

Spinal Fusion Devices Market

Orthopedic Implants Market

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]

Linkedin | Twitter | BLogs

Source Article